Celularity Inc. Email Formats
Contact top employees from
Celularity Inc.
- Celularity Inc. uses 6 different email formats. The most common is lastName (for example, doe@celularity.com), which appears in about 79% of work addresses.
- Other common patterns include:
- lastName_firstName: doe_jane@celularity.com (6%)
- lastNameInitial_firstNameInitial: d_j@celularity.com (7%)
Celularity Inc.’s Popular Email Formats
| Format | Example | Percentage |
|---|---|---|
Format lastName |  doe@celularity.com | Percentage: 79% |
Format lastNameInitial_firstNameInitial | d_j@celularity.com | Percentage: 7% |
Format lastName_firstName | doe_jane@celularity.com | Percentage: 6% |
Format lastName.firstName | doe.jane@celularity.com | Percentage: 4% |
Format firstNameInitial.lastNameInitial | j.d@celularity.com | Percentage: 2% |
Format firstName_lastNameInitial | jane_d@celularity.com | Percentage: 2% |
Contact top employees from
Celularity Inc.
Nicolas MannProject Manager
Anna GosiewskaSenior Vice President Research & Development
Rajni patelMicrobiology Manager
Megan PerezAssociate Manager, Biobanking & Donor Procurement
Rebecca GoberAssociate Manager, Facilities Operations
Megan PerezManager, Donor Operations
Monica LuchiSenior Vice President, Clinical Research & Development
Cherie FischerSenior Manager Cost Accounting
Lin KangVice President, NK Therapy
K Harold FletcherChief Legal and Strategy Officer
Diane ParksBoard Member
Sharmila KoppisettiSenior Vice President, Clinical Development and drug safety
Carlos RamirezSVP Investor Relations
William WallerSenior Vice President Finance and Controller
David BeersChief Financial Officer
Michael VirgintinoVice President Human Resources
0% completed
Verify Celularity Inc. Business Emails
Celularity Inc. employee email verification for instant deliverability checks.Companies Similar to Celularity Inc.
Celularity Inc. Corporate Information: FAQ
Celularity Inc., founded in 2016, is a biotechnology firm headquartered in Florham Park, NJ, operating within the New York Metropolitan Area (DMA). The company employs between 100–200 staff and reports revenue in the $10M–$50M range. With SIC code 2836, Celularity focuses on advanced biotechnological solutions, merging research, clinical development, and manufacturing capabilities under one organization.
Key leaders include Senior Vice President Research & Development Anna Gosiewska; Senior Vice President Clinical Research & Development Monica Luchi; Head of Commercial Finance Alan Bucher; Vice President NK Therapy Lin Kang; Vice Presidents Quality and Regulatory Affairs Sepandad Naraghi; Senior Vice President Clinical Development Sharmila Koppisetti; Senior Vice President Finance and Controller William Waller; and other executives such as Michael Virgintino (Human Resources), Mansour DJEDAINI (Scientist), Nicolas Mann (Project Manager), John Haines (Analyst) and others. The team steers innovation across research, clinical trials, quality compliance, manufacturing, finance, and corporate development.
Celularity’s operating status is “Merged,” indicating that it has integrated its operations with another entity while continuing to deliver biotech products and services. The company remains active in developing therapeutic solutions under a robust regulatory framework and a dedicated manufacturing footprint focused on cell therapy production.
Key leaders include Senior Vice President Research & Development Anna Gosiewska; Senior Vice President Clinical Research & Development Monica Luchi; Head of Commercial Finance Alan Bucher; Vice President NK Therapy Lin Kang; Vice Presidents Quality and Regulatory Affairs Sepandad Naraghi; Senior Vice President Clinical Development Sharmila Koppisetti; Senior Vice President Finance and Controller William Waller; and other executives such as Michael Virgintino (Human Resources), Mansour DJEDAINI (Scientist), Nicolas Mann (Project Manager), John Haines (Analyst) and others. The team steers innovation across research, clinical trials, quality compliance, manufacturing, finance, and corporate development.
Celularity’s operating status is “Merged,” indicating that it has integrated its operations with another entity while continuing to deliver biotech products and services. The company remains active in developing therapeutic solutions under a robust regulatory framework and a dedicated manufacturing footprint focused on cell therapy production.
Celularity Inc. uses 6 email formats across its organization. The most common pattern is lastName (e.g., doe@celularity.com), used in approximately 79% of work addresses.
Celularity Inc. currently employs over 100-200 people from United States, with a head office in Florham Park, NJ.
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
